SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive: Overexpression of SKP2 in CML is due to BCR-ABL transcriptional activity correlated to PI3K/AKT/Sp1 pathway while its deregulated expression is drove by activated Notch signaling [45].